Companies making headlines after the bell Wednesday:» Read More
NEW YORK, Sept 11- U.S. stocks fell on Thursday, dropping in a broad decline that saw the number of companies hitting 52- week lows outnumber the companies hitting highs for the first time since early August.
By Jeffrey Dastin and Daina Beth Solomon. Sept 5- New York hedge fund manager William Ackman says Herbalife is a pyramid scheme that exploits the poor.
Investing with top performing managers after a great run is probably a bad idea, according to a new study of long-term hedge fund performance.
CNBC's Scott Wapner says some big activity in the options market today around Herbalife has some traders wondering whether Bill Ackman is "pressing his short," and upping his bearish view of that company again.
Investment managers love bets made by both billionaire activists, according to a new analysis of top hedge fund stock positions.
NEW YORK, Aug 14- Activist investor Carl Icahn reported a 6.6 percent stake in Gannett Co Thursday and revealed that he planned to push the media company to split into separate print and broadcast firms before Gannett beat him to it, a regulatory filing showed.
Aug 14- Pershing Square Capital Management LP, the hedge fund firm run by William Ackman, has sued the U.S. government, claiming that its stripping of Fannie Mae's and Freddie Mac's profit illegally short changes investors in the mortgage companies' common stock.
*Recent successes include Spain's Gowex. LONDON, Aug 12- Fund managers are increasingly turning to investigative tactics, detailed accounting analysis and corporate sleuthing in a bid to uncover skeletons in company closets that can offer an investment edge in a low-yield world.
Aug 6- NU Skin Enterprises Inc, a direct-seller of skincare and nutritional products, forecast sales for the second half of the year that fell well short of analysts' expectations as its struggles to revive sales in China, its biggest market.
Ackman's Pershing Square Holdings fund has risen 27.2 percent after extending its gains modestly while many hedge fund managers suffered losses.
BOSTON, Aug 4- Billionaire investor William Ackman's Pershing Square Holdings has risen 27.2 percent this year, according to an investor in the fund, after extending its gains modestly last month when many hedge fund managers suffered losses.
Aug 1- Botox maker Allergan Inc on Friday accused rival Valeant Pharmaceuticals International and billionaire investor William Ackman of violating securities laws by using insider information as they prepared a takeover bid for the drug company.
BOSTON, July 31- Billionaire investor William Ackman called himself his "own worst enemy" in reviewing why last week's much hyped presentation on Herbalife Ltd.' s nutrition clubs failed to deliver the "death blow" he had originally promised.
Herbalife sells nutrition supplements but continues to be the target of Bill Ackman, as he alleges that the company is actually a pyramid scheme.
*Merck rises as results beat expectations, but Pfizer slips. Windstream Holdings jumped 12.8 percent to $11.88 in its busiest trading day on record after the company filed to spin off assets into a tax-efficient publicly-traded real estate investment trust.
*Pfizer, Merck rise as results beat expectations. NEW YORK, July 29- U.S. stocks rose Tuesday on news about a spinoff in the telecommunications sphere that sent most stocks in the sector soaring and on better-than-expected results from Pfizer and Merck.
*Pfizer, Merck rise as results beat expectations. NEW YORK, July 29- U.S. stocks were set to rise slightly at the open on Tuesday following better-than-expected results from companies such as Pfizer and Merck and ahead of data on consumer sentiment. Pfizer's higher-than-expected second-quarter earnings were helped by growing sales of its cancer medicines.
Herbalife slumped after posting quarterly results that fell short of estimates. Revised revenue guidance was also below projections.
*Pfizer, Merck rise as results beat expectations. NEW YORK, July 29- U.S. stock index futures edged higher on Tuesday following better-than-expected results from companies such as Pfizer and Merck and ahead of data on home prices and consumer sentiment.
Some of the names on the move ahead of the open.